PL375263A1 - 2,5-Podstawione pochodne pirymidyny jako antagoniści IX receptora CCR-3 - Google Patents
2,5-Podstawione pochodne pirymidyny jako antagoniści IX receptora CCR-3Info
- Publication number
- PL375263A1 PL375263A1 PL03375263A PL37526303A PL375263A1 PL 375263 A1 PL375263 A1 PL 375263A1 PL 03375263 A PL03375263 A PL 03375263A PL 37526303 A PL37526303 A PL 37526303A PL 375263 A1 PL375263 A1 PL 375263A1
- Authority
- PL
- Poland
- Prior art keywords
- ccr
- receptor antagonists
- pyrimidine derivatives
- substituted pyrimidine
- substituted
- Prior art date
Links
- 102000004499 CCR3 Receptors Human genes 0.000 title 1
- 108010017316 CCR3 Receptors Proteins 0.000 title 1
- 229940083082 pyrimidine derivative acting on arteriolar smooth muscle Drugs 0.000 title 1
- 150000003230 pyrimidines Chemical class 0.000 title 1
- 239000002464 receptor antagonist Substances 0.000 title 1
- 229940044551 receptor antagonist Drugs 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/18—Antivirals for RNA viruses for HIV
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/14—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing three or more hetero rings
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Pulmonology (AREA)
- Virology (AREA)
- Dermatology (AREA)
- Immunology (AREA)
- AIDS & HIV (AREA)
- Tropical Medicine & Parasitology (AREA)
- Molecular Biology (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US39352402P | 2002-07-02 | 2002-07-02 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PL375263A1 true PL375263A1 (pl) | 2005-11-28 |
Family
ID=30115597
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PL03375263A PL375263A1 (pl) | 2002-07-02 | 2003-06-25 | 2,5-Podstawione pochodne pirymidyny jako antagoniści IX receptora CCR-3 |
Country Status (11)
| Country | Link |
|---|---|
| US (1) | US6984643B2 (pl) |
| EP (1) | EP1521582A1 (pl) |
| JP (1) | JP2006502107A (pl) |
| CN (1) | CN1665506A (pl) |
| AU (1) | AU2003246587A1 (pl) |
| BR (1) | BR0312358A (pl) |
| CA (1) | CA2490148A1 (pl) |
| MX (1) | MXPA04012345A (pl) |
| PL (1) | PL375263A1 (pl) |
| RU (1) | RU2005102586A (pl) |
| WO (1) | WO2004004731A1 (pl) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| TW200619212A (en) * | 2004-09-08 | 2006-06-16 | Mitsubishi Pharma Corp | Morpholine derivatives |
| HUP0500879A2 (en) | 2005-09-22 | 2007-05-29 | Sanofi Aventis | Amide derivatives as ccr3 receptor ligands, process for producing them, pharmaceutical compositions containing them and their use and intermediates |
| CL2008001933A1 (es) * | 2007-06-29 | 2009-09-25 | Millennium Pharm Inc | Compuestos derivados de pirimidina, inhibidores de la raf quinasa; compuestos intermediarios; procedimiento de preparacion; composicion farmaceutica; y su uso para tratar trastornos proliferativos, cardiacos, neurodegenerativos, inflamatorios, oseos, inmunologicos enfermedad viral, entre otros. |
| WO2010129351A1 (en) | 2009-04-28 | 2010-11-11 | Schepens Eye Research Institute | Method to identify and treat age-related macular degeneration |
| CN102659796B (zh) * | 2012-04-05 | 2014-10-08 | 北京师范大学 | 氟-18标记的螺环哌啶类sigma-1受体化合物及制备方法和应用 |
| DK3050574T3 (da) | 2015-01-28 | 2020-01-20 | Univ Bordeaux | Anvendelse af plerixafor til behandling og/eller forebyggelse af akutte forværringer af kronisk obstruktiv lungesygdom |
| US12221463B2 (en) | 2020-08-07 | 2025-02-11 | The Board Of Regents Of The University Of Oklahoma | Method of promoting wound healing by inhibiting CCR3 |
| CN113683571B (zh) * | 2021-08-30 | 2023-02-28 | 上海日异生物科技有限公司 | 一种2-甲基-5-溴嘧啶的制备方法 |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4716166A (en) * | 1986-10-21 | 1987-12-29 | American Home Products Corporation | Histamine H1 antagonists |
| ATE163647T1 (de) | 1993-08-26 | 1998-03-15 | Ono Pharmaceutical Co | 4-aminopyrimidin derivate |
| AU716123B2 (en) | 1996-04-03 | 2000-02-17 | Merck & Co., Inc. | Inhibitors of farnesyl-protein transferase |
| EP0891361A1 (en) | 1996-04-03 | 1999-01-20 | Merck & Co., Inc. | Inhibitors of farnesyl-protein transferase |
| JP3593037B2 (ja) * | 1998-11-20 | 2004-11-24 | エフ．ホフマン−ラ ロシュ アーゲー | ピロリジン誘導体ｃｃｒ−３受容体アンタゴニスト |
| JO2308B1 (en) | 1999-05-31 | 2005-09-12 | اف. هوفمان- لاروش أيه جي | Derivatives of phenylpyrmidine |
| HRP20010969B1 (en) | 1999-06-29 | 2005-04-30 | Egis Gy�Gyszergy�R Rt. | Novel piperazinylalkylthiopyrimidine derivatives, |
| CN1192773C (zh) * | 1999-08-04 | 2005-03-16 | 帝人株式会社 | 环胺ccr3拮抗剂 |
-
2003
- 2003-06-25 AU AU2003246587A patent/AU2003246587A1/en not_active Abandoned
- 2003-06-25 MX MXPA04012345A patent/MXPA04012345A/es unknown
- 2003-06-25 RU RU2005102586/04A patent/RU2005102586A/ru not_active Application Discontinuation
- 2003-06-25 EP EP03762511A patent/EP1521582A1/en not_active Withdrawn
- 2003-06-25 JP JP2004518572A patent/JP2006502107A/ja active Pending
- 2003-06-25 WO PCT/EP2003/006698 patent/WO2004004731A1/en not_active Ceased
- 2003-06-25 BR BR0312358-8A patent/BR0312358A/pt not_active IP Right Cessation
- 2003-06-25 CN CN038159031A patent/CN1665506A/zh active Pending
- 2003-06-25 PL PL03375263A patent/PL375263A1/pl not_active Application Discontinuation
- 2003-06-25 CA CA002490148A patent/CA2490148A1/en not_active Abandoned
- 2003-07-01 US US10/611,049 patent/US6984643B2/en not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| CA2490148A1 (en) | 2004-01-15 |
| BR0312358A (pt) | 2005-04-05 |
| MXPA04012345A (es) | 2005-02-25 |
| US6984643B2 (en) | 2006-01-10 |
| US20040014775A1 (en) | 2004-01-22 |
| WO2004004731A1 (en) | 2004-01-15 |
| AU2003246587A1 (en) | 2004-01-23 |
| RU2005102586A (ru) | 2005-09-20 |
| CN1665506A (zh) | 2005-09-07 |
| JP2006502107A (ja) | 2006-01-19 |
| EP1521582A1 (en) | 2005-04-13 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| MXPA03001143A (es) | Derivados de 4-fenil-piridina como antagonistas del receptor de neuroquinina-1. | |
| AU2003259267A8 (en) | Substituted aminopyrimidines as neurokinin antagonists | |
| MXPA03005854A (es) | Derivados de quinazolona como antagonistas del receptor adrenergico alfa 1a/b. | |
| SI2308855T1 (sl) | 2,4-diaminopirimidinski derivati | |
| IL184233A0 (en) | 2,3,4,9-tetrahydro-1h-carbazole derivatives as crth2 receptor antagonists | |
| ZA200408670B (en) | Trizole derivatives as tachykinin receptor antagonists. | |
| ZA200705040B (en) | 2,4 (4,6) pyrimidine derivatives | |
| SI1224175T1 (en) | Benzodiazepine derivatives as metabotropic glutamate receptor antagonists | |
| AP2004003007A0 (en) | 3-Azabicyclo (3.1.0) hexane derivatives as oploid receptor antagonists. | |
| AU8200501A (en) | 4-phenyl-pyridine derivatives as neurokinin-1 receptor antagonists | |
| PL356990A1 (pl) | Pochodne izoksazolokarboksyamidu | |
| PL371055A1 (pl) | Pochodne azetydyny jako antagoniści receptora CCR-3 | |
| IL171930A0 (en) | Imidazole derivatives as glutamate receptor antagonists | |
| PL378753A1 (pl) | Antagoniści receptora CCR-3 | |
| IL144299A0 (en) | N-triazolymethyl-piperazine derivatives as neurokinin receptor antagonists | |
| AU2003240705A1 (en) | Morpholinylmethylureas ccr-3 receptor antagonists | |
| GB0203412D0 (en) | 5-HT 2B receptor antagonists | |
| PT1558259E (pt) | Derivados de ureia como antagonistas do receptor de il-8 | |
| IL156087A0 (en) | Histamine receptor antagonists | |
| PL370367A1 (pl) | Antagoniści V receptora CCR-3 | |
| PL370821A1 (pl) | N-Ureidopiperydyny jako antagoniści VIII receptora CCR-3 | |
| EP1809296A4 (en) | NEW [1,4] -BENZODIAZEPINES AS VASOPRESSIN V2 RECEPTOR ANTAGONISTS | |
| MXPA03009930A (es) | Antagonistas del receptor del factor liberador de corticotropina. | |
| AU2003240730A1 (en) | Morpholinylmethylureas ccr-3 receptor antagonist | |
| MXPA03005581A (es) | Pirrolidinas substituidas como antagonistas del receptor ccr-3. |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| REFS | Decisions on refusal to grant patents (taken after the publication of the particulars of the applications) |